Sensus Healthcare shares surge 17.57% after-hours as H.C. Wainwright raises price target to $12 and Lake Street initiates at $18 with 'buy' ratings.

Sensus Healthcare (NASDAQ:SRTS) surged 17.57% in after-hours trading following H.C. Wainwright’s upgrade of its price target from $11 to $12 and reaffirmation of a "buy" rating on February 11, 2025. The move followed a series of bullish analyst actions, including a $18 price target from Lake Street Capital in late January and a "buy" rating from Maxim Group in November 2024, alongside strong Q3 2024 financial results showing a 127% revenue increase. The recent analyst optimism, combined with positive coverage highlighting strategic growth initiatives and partnerships, likely drove the sharp after-hours rally, reflecting renewed confidence in the company’s revenue potential and market position.